We are live on ! Find out more

1,913 hedge funds and large institutions have $120B invested in Merck in 2016 Q4 according to their latest regulatory filings, with 205 funds opening new positions, 748 increasing their positions, 735 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more first-time investments, than exits

New positions opened: 205 | Existing positions closed: 77

5% more funds holding

Funds holding: 1,8151,913 (+98)

2% more repeat investments, than reductions

Existing positions increased: 748 | Existing positions reduced: 735

0.64% less ownership

Funds ownership: 78.18%77.55% (-0.64%)

6% less capital invested

Capital invested by funds: $127B → $120B (-$7.25B)

15% less call options, than puts

Call options by funds: $1.26B | Put options by funds: $1.47B

31% less funds holding in top 10

Funds holding in top 10: 174120 (-54)

Holders
1,913
Holders Change
+98
Holders Change %
+5.4%
% of All Funds
47.81%
Holding in Top 10
120
Holding in Top 10 Change
-54
Holding in Top 10 Change %
-31.03%
% of All Funds
3%
New
205
Increased
748
Reduced
735
Closed
77
Calls
$1.26B
Puts
$1.47B
Net Calls
-$215M
Net Calls Change
-$53.5M
Name Holding Trade Value Shares
Change
Change in
Stake
NERM
1326
New England Research & Management
Illinois
$825K +$5.38K +92 +0.6%
PFM
1327
Parsec Financial Management
North Carolina
$820K -$2.05K -35 -0.2%
PFC
1328
Poplar Forest Capital
California
$818K -$141K -2,411 -14%
ADBIC
1329
A.D. Beadell Investment Counsel
Wisconsin
$815K +$1.81K +31 +0.2%
BIAS
1330
Beacon Investment Advisory Services
New Jersey
$812K +$3.69K +63 +0.4%
Grantham, Mayo, Van Otterloo & Co (GMO)
1331
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$807K +$380K +6,498 +83%
Fuller & Thaler Asset Management
1332
Fuller & Thaler Asset Management
California
$801K
NAM
1333
Needelman Asset Management
California
$800K -$8.6K -147 -1%
BWM
1334
BerganKDV Wealth Management
Minnesota
$796K -$39.3K -671 -5%
FWP
1335
FAS Wealth Partners
Kansas
$795K +$69.2K +1,183 +9%
BDF
1336
Balasa Dinverno & Foltz
$795K +$123K +2,107 +17%
LRPA
1337
L. Roy Papp & Associates
Arizona
$793K
SFSG
1338
Stearns Financial Services Group
North Carolina
$789K -$31.1K -532 -4%
CSM
1339
CAMG Solamere Management
North Carolina
$789K +$822K +14,040 New
CAW
1340
Cornerstone Advisors (Washington)
Washington
$787K +$95.7K +1,636 +13%
MMG
1341
Monetary Management Group
Missouri
$786K -$20K -341 -2%
OIA
1342
Optimum Investment Advisors
Illinois
$785K -$3.63K -62 -0.4%
AWA
1343
Arete Wealth Advisors
Illinois
$784K +$4.92K +84 +0.6%
HJGA
1344
Hardman Johnston Global Advisors
Connecticut
$780K +$6.14K +105 +0.8%
CCM
1345
Cribstone Capital Management
Maine
$777K -$6.26K -107 -0.8%
FBC
1346
Fairfield, Bush & Co
Connecticut
$773K
SOAMC
1347
Spirit of America Management Corp
New York
$771K
TFF
1348
The Family Firm
Maryland
$771K +$644 +11 +0.1%
OAM
1349
Occidental Asset Management
California
$769K -$10.4K -178 -1%
FDS
1350
First Dallas Securities
Texas
$767K -$27.6K -471 -3%

MRK Hedge Fund Activity: Q4 2016 in Review

1,913 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2016, worth a combined $120B — down 5.7% from $127B a quarter earlier.

Buyers outnumbered sellers: 205 funds opened new MRK positions and 77 closed out — a net gain of 128 holders — while 748 added to existing stakes and 735 trimmed.

The largest buyer was Capital World Investors, adding an estimated $620M. The largest seller was Wellington Management Group, cutting an estimated $1.63B.

  • 1,913 institutional investors held Merck (MRK) as of Q4 2016, up from 1,815 in Q3 2016.
  • Funds reported $120B of Merck stock for Q4 2016, down 5.7% quarter-over-quarter.
  • 205 funds opened new Merck positions in Q4 2016 and 77 closed out, a net change of +128 holders.
  • The largest Merck buyer in Q4 2016 was Capital World Investors, an estimated $620M added.
  • The largest Merck seller in Q4 2016 was Wellington Management Group, an estimated $1.63B sold.

Based on aggregated 13F filings for Q4 2016.